Having effortlessly transitioned into acting, Fouzia's debut film swiftly captured global acclaim, earning accolades at the prestigious Cannes Film Festival
India is likely to approve Oxford/AstraZeneca's coronavirus vaccine for emergency use by next week after its local manufacturer submitted additional data sought by authorities, two sources with knowledge of the matter told Reuters on Tuesday.
This could be the first country to give the regulatory green light for the British drugmaker's vaccine as the British medicine regulator continues to examine data from the trials.
Also read: New coronavirus strain 'still not found in India'
New Covid strain: India sets new procedures for passengers from UK
India, the world's biggest vaccine-making country, wants to start inoculating its citizens next month and is also considering emergency use authorisation applications for vaccines made by Pfizer Inc and local company Bharat Biotech.
Getting vaccines to the world's second-most populous country with one of the highest infection rates will also be a big step in the battle against the pandemic.
The AstraZeneca-Oxford shot is considered vital for lower-income countries and those in hot climates because it is cheaper, easier to transport and can be stored for long periods at normal fridge temperatures.
India's Central Drugs Standard Control Organization (CDSCO) first reviewed the three applications on Dec. 9 and sought more information from all the companies, including from Serum Institute of India (SII), which is making the AstraZeneca shots.
SII, the world's biggest vaccine manufacturer, has now provided all the data, the two sources said. The authorities were still waiting for more details from Pfizer, a government health adviser told a news briefing on Tuesday, while one of the sources said additional information was expected from Bharat Biotech.
Both sources said Indian health officials were in direct contact with their British counterparts over the AstraZeneca shot and that there were "strong indications" an approval would come by next week.
The expected approval comes after data from AstraZeneca's late-stage trials in the UK and Brazil released earlier this month showed the vaccine had efficacy of 62 per cent for trial participants given two full doses, but 90 per cent for a smaller sub-group given a half, then a full dose.
The Indian regulator is only considering the two full-dose regimen of the shot despite it showing a lower success rate, the sources said.
"Serum is ready," said one of the sources. "Initially, we may get around 50 million to 60 million doses."
The sources declined to be named as deliberations were ongoing and the timeline could change.
CDSCO chief V.G. Somani did not immediately respond to a request for comment. Bharat Biotech and Pfizer declined to comment, while SII did not immediately respond to an email seeking comment.
India has not yet signed a vaccine supply deal with any company, but SII has already stockpiled more than 50 million doses of the AstraZeneca shot and plans to make a total of 400 million doses by July.
Having effortlessly transitioned into acting, Fouzia's debut film swiftly captured global acclaim, earning accolades at the prestigious Cannes Film Festival
Parag, who reached his 50 off 34 balls, cracked 25 runs with three fours and two sixes off the final over bowled by star South Africa paceman Anrich Nortje
Fans were left scratching their heads when Mumbai opted to take Bumrah out of the attack after he bowled the fourth over
With the help of modern equipment, manicured golf courses and elite athletes the scores are getting lower and the game becoming even more captivating
With 10 matches remaining Arsenal lead a three-way title race having won eight successive games
Three separate Israeli strikes on Wednesday, including on a health centre in the border village of Habariyeh, killed 11 civilians
Netanyahu tries to soothe a rift with Biden as he plans to send a government delegation to Washington after earlier cancelling the trip
Among the 24 horses Japan has sent to Dubai is impressive Riyadh Dirt Sprint winner Remake who eyes a Middle East double